Sima Sistani, the 44-year-old CEO of WeightWatchers, is aware of this, and she recognized WeightWatchers had to evolve – or else. She also landed a massive deal to buy a telehealth business that can issue virtual prescriptions to patients for these weight loss drugs. Semaglutide was approved by the US Food and Drug Administration to treat type 2 diabetes as Ozempic, but it was also used off-label for weight loss. Some longtime users of the program feel betrayed by the pivot away from in-person meetings and toward medication-based solutions. “Sadly, they don’t want to do the work,” she said, of tracking food or exercising to achieve weight loss goals.

---

Persons: New York CNN —, Sima Sistani, WeightWatchers, she’s, Sistani, “, ” Sistani, Erica Shroeder, ”, Jaap Arriens, ” Goldman Sachs, Jenny Craig, Adam Rockmore, Ged, Angela Weiss, Variety Sistani, there’s, Semaglutide, aren’t, “ there’s, Oprah Winfrey, Jamie Yonash, influencers, Velanti, Michael Nagle, We’re Organizations: New, New York CNN, Walmart, CNN, WeightWatchers, Variety, US Food and Drug Administration, Bloomberg, Getty Locations: New York, Cola, Wegovy